• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cytogenetic findings in 200 patients with multiple myeloma.

作者信息

Sawyer J R, Waldron J A, Jagannath S, Barlogie B

机构信息

Department of Pathology, University of Arkansas for Medical Sciences, Arkansas Cancer Research Center, Little Rock, USA.

出版信息

Cancer Genet Cytogenet. 1995 Jul 1;82(1):41-9. doi: 10.1016/0165-4608(94)00284-i.

DOI:10.1016/0165-4608(94)00284-i
PMID:7627933
Abstract

Cytogenetic studies were performed in 200 consecutive patients with multiple myeloma and related disorders. Structurally or numerically abnormal clones were found in 63 patients (32%), including 8 of 45 untreated patients (18%), and 55 of 155 treated patients (35%). The abnormal karyotypes generally showed numerous numerical and structural aberrations and in some patients multiple abnormal clones. The most striking feature of patients with hyperdiploid karyotypes was the finding of consistent recurring trisomies for chromosomes 3, 5, 7, 9, 11, 15, 19, and 21, cosegregating together in many cases. Monosomy for chromosome 13 was the most common chromosome loss, occurring in 18 abnormal patients (29%), while interstitial deletions involving band 13q14 occurred in an additional 9 patients, indicating a loss of all or part of chromosome 13 in a high percentage of patients with abnormal karyotypes (43%). Structural aberrations of chromosome 1 were most frequent, occurring in 30 of 63 patients (48%), and involved almost equally the short and long arms. The single most frequent chromosome breakpoint involved band 14q32 and was found in 21 patients (33%), including 11 patients with a 14q+ chromosome, 8 with t(11;14)(q13;q32), and 2 with t(8;14)(q24;132).

摘要

相似文献

1
Cytogenetic findings in 200 patients with multiple myeloma.
Cancer Genet Cytogenet. 1995 Jul 1;82(1):41-9. doi: 10.1016/0165-4608(94)00284-i.
2
Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.120例核型异常的多发性骨髓瘤病例中的染色体畸变
Am J Hematol. 2007 Dec;82(12):1080-7. doi: 10.1002/ajh.20998.
3
Cytogenetics of multiple myeloma.多发性骨髓瘤的细胞遗传学
Coll Antropol. 2010 Mar;34(1):41-4.
4
Karyotype in multiple myeloma and plasma cell leukaemia.
Eur J Cancer. 1993;29A(9):1269-73. doi: 10.1016/0959-8049(93)90071-m.
5
Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.21例多发性骨髓瘤和浆细胞白血病患者中14q32.3和19p13.3的非随机染色体重排以及1p的优先缺失。
Blood. 1994 Oct 1;84(7):2283-90.
6
Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.多发性骨髓瘤的细胞遗传学:荧光原位杂交结果解读
Br J Haematol. 2003 Mar;120(6):944-52. doi: 10.1046/j.1365-2141.2003.04172.x.
7
Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.采用间期荧光原位杂交技术研究多发性骨髓瘤患者的分子细胞遗传学畸变。
Exp Oncol. 2007 Jun;29(2):116-20.
8
Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations.多发性骨髓瘤中的der(16)t(1;16)(q10;p10):一种新的非随机异常,常与伯基特型易位相关。
Leukemia. 1995 Feb;9(2):277-81.
9
Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.多发性骨髓瘤细胞遗传学异常与疾病特征之间的相关性:13号染色体单体和11q结构异常与高比例的S期浆细胞相关。
Haematologica. 2000 Nov;85(11):1146-52.
10
[Cytogenetic study of multiple myeloma].[多发性骨髓瘤的细胞遗传学研究]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Feb;15(1):76-8.

引用本文的文献

1
Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets.肿瘤性浆细胞的单细胞分析鉴定出骨髓瘤病理生物学介质和潜在靶点。
Cell Rep Med. 2025 Feb 18;6(2):101925. doi: 10.1016/j.xcrm.2024.101925. Epub 2025 Jan 23.
2
KDM6A regulates immune response genes in multiple myeloma.KDM6A 调控多发性骨髓瘤中的免疫反应基因。
Blood. 2024 Oct 3;144(14):1508-1520. doi: 10.1182/blood.2024024518.
3
Non-Secretory Multiple Myeloma Associated With High-Risk Phenotype and Complex Cytogenetics Including t(8;22).
与高风险表型及包括t(8;22)在内的复杂细胞遗传学相关的非分泌型多发性骨髓瘤
J Hematol. 2024 Jun;13(3):94-98. doi: 10.14740/jh1248. Epub 2024 Jun 28.
4
Cytogenetic Alterations and Correlation with Age and Gender in Patients of Multiple Myeloma: A Study from a Tertiary Care Center in Eastern India.多发性骨髓瘤患者的细胞遗传学改变及其与年龄和性别的相关性:来自印度东部一家三级医疗中心的研究
South Asian J Cancer. 2024 Feb 12;13(2):126-131. doi: 10.1055/s-0043-1761441. eCollection 2024 Apr.
5
Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysis.治疗多发性骨髓瘤后的治疗相关髓系肿瘤:单中心分析。
Ann Hematol. 2022 May;101(5):1031-1038. doi: 10.1007/s00277-022-04775-1. Epub 2022 Mar 9.
6
Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.多发性骨髓瘤肿瘤演变的单细胞分析——精准医学的机遇
Nat Rev Clin Oncol. 2022 Apr;19(4):223-236. doi: 10.1038/s41571-021-00593-y. Epub 2022 Jan 11.
7
Chromosome 1q21 abnormalities in multiple myeloma.多发性骨髓瘤中 1q21 染色体异常。
Blood Cancer J. 2021 Apr 29;11(4):83. doi: 10.1038/s41408-021-00474-8.
8
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression.多发性骨髓瘤的基因分析确定了与疾病复杂性和进展相关的细胞遗传学改变。
Cancers (Basel). 2021 Jan 29;13(3):517. doi: 10.3390/cancers13030517.
9
Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases.多发性骨髓瘤的传统细胞遗传学和间期荧光原位杂交结果:土耳其一家实验室对381例病例的分析
Indian J Hematol Blood Transfus. 2020 Apr;36(2):284-291. doi: 10.1007/s12288-019-01215-5. Epub 2019 Oct 25.
10
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.1q21 增益合并高危因素是中国新诊断多发性骨髓瘤的异质性预后因素:一项多中心研究。
Oncologist. 2019 Nov;24(11):e1132-e1140. doi: 10.1634/theoncologist.2019-0132. Epub 2019 Aug 27.